שווי כולל של החברה: VivoSim Labs (VIVS)

Deliveries of bioprinters and specialized gels are strictly controlled via a network of express carriers, eliminating delivery disruptions. The reliability of the living structures chain is ensured by temperature control and medical courier services. The stock chart for VivoSim Labs Inc (VIVS) shows that the enterprise value is 1.14. The use of 3D tissue printing for pharmaceutical testing and partnerships with numerous laboratories significantly reduce the financial risks of this biotech business.

This metric reflects the objective value of the entire physical business, accounting for liabilities and liquidity, while stripping market noise from the valuation. By summing market capitalization and debt minus cash, the enterprise value indicator demonstrates the actual acquisition price of VivoSim Labs Inc. (VIVS), where growth in this metric confirms the capitalization of successes in 3D bioprinting commercialization and the expansion of B2B sales of customized organ models.